Reconfiguring Nature (2004)
Issues and Debates in the New Genetics
Herausgeber: Glasner, Peter
Reconfiguring Nature (2004)
Issues and Debates in the New Genetics
Herausgeber: Glasner, Peter
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Published in 2004, this collection will encourage and foster informed discussion of key issues as society comes to grips with the implications of genetic engineering, the mapping and sequencing of the human genome, and the advent of the post-genomic era.
Andere Kunden interessierten sich auch für
- Mehmoona Moosa-MithaReconfiguring Citizenship73,99 €
- Moral Anthropology77,99 €
- Changing Values and Beliefs in 85 Countries70,99 €
- Shaun Kingsley MalarneyCulture, Ritual and Revolution in Vietnam48,99 €
- Martin Bulmer / John Solomos (eds.)Researching Race and Racism58,99 €
- Christine J WinterSubjects of Intergenerational Justice59,99 €
- Erkan AliInterpreting Visual Ethnography58,99 €
-
-
-
Published in 2004, this collection will encourage and foster informed discussion of key issues as society comes to grips with the implications of genetic engineering, the mapping and sequencing of the human genome, and the advent of the post-genomic era.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 344
- Erscheinungstermin: 31. März 2021
- Englisch
- Abmessung: 234mm x 155mm x 20mm
- Gewicht: 522g
- ISBN-13: 9780815347101
- ISBN-10: 0815347103
- Artikelnr.: 60010912
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 344
- Erscheinungstermin: 31. März 2021
- Englisch
- Abmessung: 234mm x 155mm x 20mm
- Gewicht: 522g
- ISBN-13: 9780815347101
- ISBN-10: 0815347103
- Artikelnr.: 60010912
Peter Glasner works at the ESRC Centre for the Economic and Social Aspects of Genomics at Cardiff University, UK.
1. Introduction: What's New bout the 'New Genetics'?, Peter Glasner and
Harry Rothman. Part I: Literacy, Public Understanding and the Media. 2. The
Gene Shop at Manchester Airport, Mairi Levitt. 3. Public Understanding of
Genetic Engineering in Germany, Jurgen Hampel. 4. Predictive Medicine,
Genetics and Schizophrenia, John Turney and Jill Turner. Part II:
Commercialization and Health. 5. Pharmacogenetics: Implications for Drug
Development, Patients and Society, Alun McCarthy. 6. The Use of Large
Biological Sample Collections in Genetics Research: Issues for Public
Policy, Paul Martin and Jane Kaye. Part III: Gen-ethics: Human Genetic
Banking. 7. DNA Sampling and Banking in Clinical Genetics and Genetic
Research, Kare Berg. 8. Human Genetic Banking and the Limits of Informed
Consent, Garrath Williams and Doris Schroeder. 9. Regulation and Social
Perceptions of Genetic Data Banking in Germany, Juergen Simon and Susanne
Braun. Part IV: Genetic Screening: Genetic and Nongenetic Medical
Information: Is there a Moral Difference in the Context of Insurance?,
Veikko Launis. 11. New Practices of Screening in the Field of
Cancergenetics: A Co-evolutionary Perspective, Dirk Stemerding and Annemiek
Nelis. 12. Lumping and Splitting Revisited: Or what Happens when the New
Genetics Meets Disease Classification, Adam M. Hedgecoe. Part V: Cloning
and Xenotransplantation. 13. What We Know and What We Don't Know about
Cloning and Society, Sarah Franklin. 14. Containing Contradictions:
Debating Nature, Controversy and Biotechnology, Nik Brown. 15. Constructing
the Scientific Citizen: Science and Democracy in the Biosciences, Alan
Irwin. 16. Conclusion, Peter Glasner.
Harry Rothman. Part I: Literacy, Public Understanding and the Media. 2. The
Gene Shop at Manchester Airport, Mairi Levitt. 3. Public Understanding of
Genetic Engineering in Germany, Jurgen Hampel. 4. Predictive Medicine,
Genetics and Schizophrenia, John Turney and Jill Turner. Part II:
Commercialization and Health. 5. Pharmacogenetics: Implications for Drug
Development, Patients and Society, Alun McCarthy. 6. The Use of Large
Biological Sample Collections in Genetics Research: Issues for Public
Policy, Paul Martin and Jane Kaye. Part III: Gen-ethics: Human Genetic
Banking. 7. DNA Sampling and Banking in Clinical Genetics and Genetic
Research, Kare Berg. 8. Human Genetic Banking and the Limits of Informed
Consent, Garrath Williams and Doris Schroeder. 9. Regulation and Social
Perceptions of Genetic Data Banking in Germany, Juergen Simon and Susanne
Braun. Part IV: Genetic Screening: Genetic and Nongenetic Medical
Information: Is there a Moral Difference in the Context of Insurance?,
Veikko Launis. 11. New Practices of Screening in the Field of
Cancergenetics: A Co-evolutionary Perspective, Dirk Stemerding and Annemiek
Nelis. 12. Lumping and Splitting Revisited: Or what Happens when the New
Genetics Meets Disease Classification, Adam M. Hedgecoe. Part V: Cloning
and Xenotransplantation. 13. What We Know and What We Don't Know about
Cloning and Society, Sarah Franklin. 14. Containing Contradictions:
Debating Nature, Controversy and Biotechnology, Nik Brown. 15. Constructing
the Scientific Citizen: Science and Democracy in the Biosciences, Alan
Irwin. 16. Conclusion, Peter Glasner.
1. Introduction: What's New bout the 'New Genetics'?, Peter Glasner and
Harry Rothman. Part I: Literacy, Public Understanding and the Media. 2. The
Gene Shop at Manchester Airport, Mairi Levitt. 3. Public Understanding of
Genetic Engineering in Germany, Jurgen Hampel. 4. Predictive Medicine,
Genetics and Schizophrenia, John Turney and Jill Turner. Part II:
Commercialization and Health. 5. Pharmacogenetics: Implications for Drug
Development, Patients and Society, Alun McCarthy. 6. The Use of Large
Biological Sample Collections in Genetics Research: Issues for Public
Policy, Paul Martin and Jane Kaye. Part III: Gen-ethics: Human Genetic
Banking. 7. DNA Sampling and Banking in Clinical Genetics and Genetic
Research, Kare Berg. 8. Human Genetic Banking and the Limits of Informed
Consent, Garrath Williams and Doris Schroeder. 9. Regulation and Social
Perceptions of Genetic Data Banking in Germany, Juergen Simon and Susanne
Braun. Part IV: Genetic Screening: Genetic and Nongenetic Medical
Information: Is there a Moral Difference in the Context of Insurance?,
Veikko Launis. 11. New Practices of Screening in the Field of
Cancergenetics: A Co-evolutionary Perspective, Dirk Stemerding and Annemiek
Nelis. 12. Lumping and Splitting Revisited: Or what Happens when the New
Genetics Meets Disease Classification, Adam M. Hedgecoe. Part V: Cloning
and Xenotransplantation. 13. What We Know and What We Don't Know about
Cloning and Society, Sarah Franklin. 14. Containing Contradictions:
Debating Nature, Controversy and Biotechnology, Nik Brown. 15. Constructing
the Scientific Citizen: Science and Democracy in the Biosciences, Alan
Irwin. 16. Conclusion, Peter Glasner.
Harry Rothman. Part I: Literacy, Public Understanding and the Media. 2. The
Gene Shop at Manchester Airport, Mairi Levitt. 3. Public Understanding of
Genetic Engineering in Germany, Jurgen Hampel. 4. Predictive Medicine,
Genetics and Schizophrenia, John Turney and Jill Turner. Part II:
Commercialization and Health. 5. Pharmacogenetics: Implications for Drug
Development, Patients and Society, Alun McCarthy. 6. The Use of Large
Biological Sample Collections in Genetics Research: Issues for Public
Policy, Paul Martin and Jane Kaye. Part III: Gen-ethics: Human Genetic
Banking. 7. DNA Sampling and Banking in Clinical Genetics and Genetic
Research, Kare Berg. 8. Human Genetic Banking and the Limits of Informed
Consent, Garrath Williams and Doris Schroeder. 9. Regulation and Social
Perceptions of Genetic Data Banking in Germany, Juergen Simon and Susanne
Braun. Part IV: Genetic Screening: Genetic and Nongenetic Medical
Information: Is there a Moral Difference in the Context of Insurance?,
Veikko Launis. 11. New Practices of Screening in the Field of
Cancergenetics: A Co-evolutionary Perspective, Dirk Stemerding and Annemiek
Nelis. 12. Lumping and Splitting Revisited: Or what Happens when the New
Genetics Meets Disease Classification, Adam M. Hedgecoe. Part V: Cloning
and Xenotransplantation. 13. What We Know and What We Don't Know about
Cloning and Society, Sarah Franklin. 14. Containing Contradictions:
Debating Nature, Controversy and Biotechnology, Nik Brown. 15. Constructing
the Scientific Citizen: Science and Democracy in the Biosciences, Alan
Irwin. 16. Conclusion, Peter Glasner.